Rafael Martínez

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

Gema Mateo, María-Ángeles Montalbán, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2008 · 210 citations · Full text

Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

Enric Carreras, Laura Rosiñol, María José Terol et al. · Biology of Blood and Marrow Transplantation · 2007 · 92 citations · Full text

Cell Therapy, Immunology, Pathology +21

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

Bruno Paiva, María‐Belén Vídriales, Gema Mateo et al. · Blood · 2009 · 75 citations · Full text

Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin’s Lymphoma Study Group

Carlos Montalbán, Juan F. Garcı́a, Víctor Abraira et al. · Journal of Clinical Oncology · 2004 · 69 citations · Full text

Prognostic Value of Immune Profiling Multiple Myeloma Patients during Minimal Residual Disease Monitoring in the Pethema/GEM2010MAS65 Study

Paula Arana, Bruno Paiva, Noemí Puig et al. · Blood · 2015 · 65 citations